Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 117

    1.

    Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial.

    Rosenstock J, Cefalu WT, Hollander PA, Klioze SS, Reis J, Duggan WT.

    Diabetes Technol Ther. 2009 Nov;11(11):697-705.PMID: 19905885 [PubMed - in process]Related articles

    2.

    Saxagliptin Added to a Thiazolidinedione Improves Glycemic Control in Patients with Type 2 Diabetes and Inadequate Control on Thiazolidinedione Alone.

    Hollander P, Li J, Allen E, Chen R; for the CV181-013 Investigators.

    J Clin Endocrinol Metab. 2009 Oct 28. [Epub ahead of print]PMID: 19864452 [PubMed - as supplied by publisher]Related articles

    4.

    Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.

    Skyler JS, Hollander PA, Jovanovic L, Klioze S, Krasner A, Riese RJ, Reis J, Schwartz P, Duggan W; Inhaled Human Insulin Type 1 Diabetes Study Group.

    Diabetes Res Clin Pract. 2008 Nov;82(2):238-46. Epub 2008 Sep 27.PMID: 18824271 [PubMed - indexed for MEDLINE]Related articles

    6.

    Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes.

    Rosenstock J, Cefalu WT, Hollander PA, Belanger A, Eliaschewitz FG, Gross JL, Klioze SS, St Aubin LB, Foyt H, Ogawa M, Duggan WT.

    Diabetes Care. 2008 Sep;31(9):1723-8. Epub 2008 Jun 5.PMID: 18535196 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine.

    Bergenstal RM, Johnson M, Powers MA, Wynne A, Vlajnic A, Hollander P, Rendell M.

    Diabetes Care. 2008 Jul;31(7):1305-10. Epub 2008 Mar 25.PMID: 18364392 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A procedure for intravenous injection using external jugular vein in Mongolian gerbil (Meriones unguiculatus).

    Kakol Palm D, Holländer P.

    Lab Anim. 2007 Jul;41(3):403-5.PMID: 17640467 [PubMed - indexed for MEDLINE]Related articles

    9.

    Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.

    Hollander P, Yu D, Chou HS.

    Arch Intern Med. 2007 Jun 25;167(12):1284-90.PMID: 17592102 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials.

    Hollander PA, Krasner A, Klioze S, Schwartz P, Duggan W.

    Diabetes Care. 2007 Oct;30(10):2508-10. Epub 2007 May 29. No abstract available. PMID: 17536080 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes.

    Hollander PA.

    MedGenMed. 2007 Mar 5;9(1):45. Review.PMID: 17435648 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound.

    Sigfridsson K, Forssén S, Holländer P, Skantze U, de Verdier J.

    Eur J Pharm Biopharm. 2007 Sep;67(2):540-7. Epub 2007 Feb 17.PMID: 17383167 [PubMed - indexed for MEDLINE]Related articles

    13.

    A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients.

    Rosenstock J, Hollander P, Gadde KM, Sun X, Strauss R, Leung A; OBD-202 Study Group.

    Diabetes Care. 2007 Jun;30(6):1480-6. Epub 2007 Mar 15.PMID: 17363756 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus.

    Hollander P.

    Am J Med. 2007 Feb;120(2 Suppl 1):S18-28; discussion S29-32.PMID: 17296341 [PubMed - indexed for MEDLINE]Related articles

    15.

    The Editor's Roundtable: the metabolic syndrome.

    Friedewald VE, Grundy S, Gotto AM Jr, Haffner S, Denke MA, Hollander P, Roberts WC.

    Am J Cardiol. 2007 Feb 1;99(3):382-9. Epub 2006 Dec 8. No abstract available. PMID: 17261403 [PubMed - indexed for MEDLINE]Related articles

    16.

    Basal insulin or premix analogue therapy in type 2 diabetes patients.

    Raskin PR, Hollander PA, Lewin A, Gabbay RA, Bode B, Garber AJ; on behalf of the INITIATE Study Group.

    Eur J Intern Med. 2007 Jan;18(1):56-62.PMID: 17223044 [PubMed - in process]Related articles

    17.

    Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

    Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF; RIO-Diabetes Study Group.

    Lancet. 2006 Nov 11;368(9548):1660-72. Erratum in: Lancet. 2006 Nov 11;368(9548):1650. PMID: 17098084 [PubMed - indexed for MEDLINE]Related articles

    18.

    Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults.

    Erondu N, Gantz I, Musser B, Suryawanshi S, Mallick M, Addy C, Cote J, Bray G, Fujioka K, Bays H, Hollander P, Sanabria-Bohórquez SM, Eng W, Långström B, Hargreaves RJ, Burns HD, Kanatani A, Fukami T, MacNeil DJ, Gottesdiener KM, Amatruda JM, Kaufman KD, Heymsfield SB.

    Cell Metab. 2006 Oct;4(4):275-82.PMID: 17011500 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effectiveness of diabetes resource nurse case management and physician profiling in a fee-for-service setting: a cluster randomized trial.

    Herrin J, Nicewander DA, Hollander PA, Couch CE, Winter FD, Haydar ZR, Warren SS, Ballard DJ.

    Proc (Bayl Univ Med Cent). 2006 Apr;19(2):95-102.PMID: 16609732 [PubMed - as supplied by publisher]Related articlesFree article

    20.

    Training with inspiratory pressure support in patients with severe COPD.

    van 't Hul A, Gosselink R, Hollander P, Postmus P, Kwakkel G.

    Eur Respir J. 2006 Jan;27(1):65-72.PMID: 16387937 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) interacts with PELP1 and activates MAPK.

    Rayala SK, Hollander P, Balasenthil S, Molli PR, Bean AJ, Vadlamudi RK, Wang RA, Kumar R.

    J Biol Chem. 2006 Feb 17;281(7):4395-403. Epub 2005 Dec 12.PMID: 16352611 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Quality of care of Medicare patients with diabetes in a metropolitan fee-for-service primary care integrated delivery system.

    Hollander P, Nicewander D, Couch C, Winter D, Herrin J, Haydar Z, Ballard DJ.

    Am J Med Qual. 2005 Nov-Dec;20(6):344-52.PMID: 16280398 [PubMed - indexed for MEDLINE]Related articles

    23.

    Clinical outcomes in patients with type 2 diabetes managed by a diabetes resource nurse in a primary care practice.

    Couch C, Sheffield P, Gerthoffer T, Ries A, Hollander P.

    Proc (Bayl Univ Med Cent). 2003 Jul;16(3):336-40.PMID: 16278705 [PubMed]Related articlesFree article

    24.

    Evaluation of a multi-parameter biomarker set for oxidative damage in man: increased urinary excretion of lipid, protein and DNA oxidation products after one hour of exercise.

    Orhan H, van Holland B, Krab B, Moeken J, Vermeulen NP, Hollander P, Meerman JH.

    Free Radic Res. 2004 Dec;38(12):1269-79.PMID: 15763951 [PubMed - indexed for MEDLINE]Related articles

    25.

    Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

    Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A; INITIATE Study Group.

    Diabetes Care. 2005 Feb;28(2):260-5.PMID: 15677776 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Cherchez la femme, cherchez la femme: a paradoxical response to trauma.

    Hollander P.

    Psychiatry. 2004 Fall;67(3):212-6.PMID: 15491933 [PubMed - indexed for MEDLINE]Related articles

    27.

    Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

    Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson JL, Levin SR.

    Diabetes Care. 2004 Oct;27(10):2356-62.PMID: 15451900 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients.

    Hollander P, Maggs DG, Ruggles JA, Fineman M, Shen L, Kolterman OG, Weyer C.

    Obes Res. 2004 Apr;12(4):661-8.PMID: 15090634 [PubMed - indexed for MEDLINE]Related articles

    29.

    Quadriceps muscle endurance in patients with chronic obstructive pulmonary disease.

    Van't Hul A, Harlaar J, Gosselink R, Hollander P, Postmus P, Kwakkel G.

    Muscle Nerve. 2004 Feb;29(2):267-74.PMID: 14755493 [PubMed - indexed for MEDLINE]Related articles

    30.

    Acute effects of inspiratory pressure support during exercise in patients with COPD.

    van 't Hul A, Gosselink R, Hollander P, Postmus P, Kwakkel G.

    Eur Respir J. 2004 Jan;23(1):34-40.PMID: 14738228 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets.

    Hollander P, Ratner R, Fineman M, Strobel S, Shen L, Maggs D, Kolterman O, Weyer C.

    Diabetes Obes Metab. 2003 Nov;5(6):408-14.PMID: 14617226 [PubMed - indexed for MEDLINE]Related articles

    32.

    Orlistat in the treatment of obesity.

    Hollander P.

    Prim Care. 2003 Jun;30(2):427-40. Review.PMID: 14567157 [PubMed - indexed for MEDLINE]Related articles

    33.

    Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis.

    Schwartz S, Sievers R, Strange P, Lyness WH, Hollander P; INS-2061 Study Team.

    Diabetes Care. 2003 Aug;26(8):2238-43.PMID: 12882842 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.

    Raskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM; Repaglinide vs. Nateglinide Metformin Combination Study Group.

    Diabetes Care. 2003 Jul;26(7):2063-8. Erratum in: Diabetes Care. 2003 Sep;26(9):2708. PMID: 12832314 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity.

    Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH.

    Obes Res. 2003 Jun;11(6):722-33.PMID: 12805393 [PubMed - indexed for MEDLINE]Related articles

    36.

    Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.

    Hollander PA, Levy P, Fineman MS, Maggs DG, Shen LZ, Strobel SA, Weyer C, Kolterman OG.

    Diabetes Care. 2003 Mar;26(3):784-90.PMID: 12610038 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

    Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S.

    Diabetes Care. 2002 Jul;25(7):1123-8. Erratum in: Diabetes Care. 2002 Sep;25(9):1671.. PMID: 12087008 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

    Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P.

    Diabetes Care. 2002 Jun;25(6):1033-41. Erratum in: Diabetes Care. 2003 Mar;26(3):971.. PMID: 12032111 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Orlistat: A Viewpoint by Priscilla A. Hollander.

    Hollander PA.

    Drugs. 2001;61(14):2120-2121. No abstract available. PMID: 11735641 [PubMed - as supplied by publisher]Related articles

    40.

    Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.

    Hollander PA, Schwartz SL, Gatlin MR, Haas SJ, Zheng H, Foley JE, Dunning BE.

    Diabetes Care. 2001 Jun;24(6):983-8.PMID: 11375357 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Current trends in treating type 2 diabetes.

    Hollander PA.

    Postgrad Med. 2000 May 15;107(6 Suppl Key):4-10. Review.PMID: 19667504 [PubMed - indexed for MEDLINE]Related articles

    42.

    Physical performance in persons with spinal cord injuries after discharge from rehabilitation.

    Dallmeijer AJ, van der Woude LH, Hollander PA, Angenot EL.

    Med Sci Sports Exerc. 1999 Aug;31(8):1111-7.PMID: 10449012 [PubMed - indexed for MEDLINE]Related articles

    43.

    Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

    Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J.

    Diabetes Care. 1998 Aug;21(8):1288-94.PMID: 9702435 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Acarbose in the treatment of type I diabetes.

    Hollander P, Pi-Sunyer X, Coniff RF.

    Diabetes Care. 1997 Mar;20(3):248-53.PMID: 9051366 [PubMed - indexed for MEDLINE]Related articles

    45.

    New oral agents for type II diabetes. Taking a more aggressive approach to therapy.

    Hollander PA.

    Postgrad Med. 1995 Dec;98(6):110-1, 115-6, 119-21, passim.PMID: 7501573 [PubMed - indexed for MEDLINE]Related articles

    46.

    Comparing methods of estimating maximum allowable analytical error in glycohemoglobin testing.

    Kolatkar NS, Weiss SL, Cembrowski GS, Mazze RS, Hollander P.

    Am J Clin Pathol. 1995 Jun;103(6):771-2. No abstract available. PMID: 7785664 [PubMed - indexed for MEDLINE]Related articles

    47.

    A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.

    Biesbroeck R, Bril V, Hollander P, Kabadi U, Schwartz S, Singh SP, Ward WK, Bernstein JE.

    Adv Ther. 1995 Mar-Apr;12(2):111-20.PMID: 10150323 [PubMed - indexed for MEDLINE]Related articles

    48.

    Intensified insulin regimens. Should they be used in all patients with type I diabetes?

    Hollander P.

    Postgrad Med. 1994 Sep 1;96(3):63-8, 72. Review.PMID: 8072915 [PubMed - indexed for MEDLINE]Related articles

    49.

    Helping patients manage intensified insulin regimens.

    Hollander P, Castle G, Joynes JO, Nelson J.

    Nursing. 1993 Oct;23(10):48-52. No abstract available. PMID: 8414256 [PubMed - indexed for MEDLINE]Related articles

    50.

    [Efficiency of portable sleep apnea screening instruments]

    Netzer N, Randelshofer W, Holländer P, Petro W.

    Pneumologie. 1993 Mar;47 Suppl 1:126-9. German. PMID: 8497463 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...